Xinlitai's new drug for depression, SAL0114 tablets, has been out of the pain of centralized procurement after the clinical performance has rebounded sharply

  • Post date April 22, 2022 — 01:20 Post Lock Login to View

Key Data Concepts:   
? These are the company names, stock quotes, topics, and entities related to this data.

002294 002422 300170 300705 300713 Hand Enterprise Solutions Hunan Jiudian Pharmaceutical Jiangsu Hengrui Medicine Shenzhen Salubris Pharmaceuticals Shenzhenrease Technology Sichuan Kelun Pharmaceutical Witness Accounting, Audit Annual, Special Corporate Meeting Annual Report Research, Development Health, Beauty Product Pharmaceutical Construction, Property Financial, Business Service Insurance Gold, Precious Material Market, Exchange Securities Diseases, Conditions Illness Medicine Health Insurance Records, Achievements People Workplace Health, Safety Food, Drink Enthusiasm Trend Food, Drink Regulations Surgery Health

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login



Related Data